Related Experiment Video
Updated: Jun 16, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
[An evidence based Iberic-Latin American guideline for acute gastroenteritis management in infants and prescholars]
P Gutiérrez Castrellón1, I Polanco Allué, E Salazar Lindo
1Instituto Nacional de Pediatría, Centro de Análisis de la Evidencia COCHRANE-INPed, Red COCHRANE Mexicana, Ministerio de Salud, México.
Insights
For acute gastroenteritis (AG) in young children, oral rehydration solutions are the primary treatment, offering fewer complications than IV fluids. A normal diet and specific supplements like zinc can aid recovery.
Area of Science:
- Pediatrics
- Infectious Diseases
- Gastroenterology
Background:
- Acute gastroenteritis (AG) presents significant morbidity and mortality in infants and preschoolers, particularly in developing nations.
- Existing treatment guidelines require evidence-based updates to support clinical decision-making for pediatric AG.
Purpose of the Study:
- To develop an evidence-based document to guide therapeutic decisions for acute gastroenteritis in children under five years old.
- To provide recommendations for the management of acute gastroenteritis in infants and young children based on systematic literature review and expert consensus.
Main Methods:
- A systematic literature review was conducted in May 2008.
- Evidence was graded using Oxford guidelines, and recommendations were refined by Latin American experts.
Main Results:
- Oral rehydration solutions (ORS) are the cornerstone of AG treatment, demonstrating fewer complications compared to intravenous (IV) fluids.
- A normal diet is not contraindicated during AG. Racecadotril, zinc, and smectite, along with probiotics like Lactobacillus GG and Saccharomyces boulardii, can be beneficial adjuncts.
- No other medications are recommended for AG treatment.
Conclusions:
- Oral rehydration solutions should be the primary treatment for acute gastroenteritis in children.
- Adjunctive therapies including racecadotril, zinc, smectite, and specific probiotics are recommended alongside ORS for managing pediatric AG.
Abstract:
Acute gastroenteritis (AG) morbidity and mortality rates in infants and prescholars continue to be high in developing countries. Authors want to develop an evidence-based document that supports decision making regarding AG therapy in infants and children younger than 5 y/o. A systematic review of the literature was performed (May, 2008). Evidence grading was established according to Oxford guidelines and Latin American experts submitted their opinions on the recommendations generated. Oral rehydration solutions are the threatment's keystone for children with AG, showing lesser complications due to therapy than IV fluids. AG is no contraindication of a normal diet. Racecadotril, zinc and smectite can contribute to AG treatment, as well as Lactobacillus GG and Saccharomycces boulardii. No other drugs are recommended. It is recommended to treat children presenting AG with oral rehydration solutions among racecadotril, zinc or smectite as well as some probiotics.
Related Concept Videos
Bacterial Gastroenteritis
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Drug Dosing: Infants and Children
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
